DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 94 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactResults

Gland Pharma Limited — Outcome of Board Meeting

NSE 2 hrs ago·6 Nov 2026, 11:03 am

Gland Pharma

Gland Pharma Limited has announced the financial results for the period ending September 30, 2026, following a board meeting. The company has submitted these details to the stock exchange, providing an update on its quarterly performance.

For investors, this disclosure is a routine step that signals the conclusion of the reporting period. It allows the market to assess the company's current financial health and operational progress against its previous performance.

Investors should look closely at the specific figures within the report, including revenue growth and profit margins. Monitoring these metrics will help determine if the company is meeting its targets and provide insight into its future trajectory.